NCT06779851
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06779851
Title A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors (SUMMIT-1)
Acronym SUMMIT-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bright Peak Therapeutics Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.